Fierce Biotech May 1, 2024
Eli Lilly’s explosion into the weight loss space is proving fruitful for shareholders, but it’s also providing fresh opportunities for biotechs looking for a Big Pharma partnership.
Lilly’s incubator arm, Gateway Labs, already operates two sites in South Francisco. The organization is set to expand to the east coast in August via a presence at the Lilly Institute for Genetic Medicine in Boston’s Seaport district. That will be followed by another opening later this year in San Diego.
The Gateway Labs are co-working spaces for researchers that also act like accelerators. The idea is that companies or researchers that lease space have the opportunity to collaborate on mutually beneficial research and tap into Lilly’s expertise.
“We’re really excited to expand...
Today's Sponsors
Today's Sponsor